Michela Luciano, PhD,  Science Writer—

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg. Her research focused on the role of inflammation in Acute Myeloid Leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as Scientific Writer in 2022. Outside of work, she enjoys street photography, mountain hikes, running, and spending as much time as possible outdoors.

Articles by Michela Luciano, PhD

March 6, 2025 News by Michela Luciano, PhD

Woolsey secures additional funding to advance ALS therapy Bravyl

Woolsey Pharmaceuticals has extended its Series B preferred financing round, securing additional funds to continue advancing its ROCK inhibitor Bravyl (oral fasudil) for amyotrophic lateral sclerosis (ALS). The extension was completed with participation from existing investors. Series B financing is an early round of funding that usually takes…

Recent Posts